RGT Capital Management Ltd. Invests $303,000 in Monsanto Company (MON)
RGT Capital Management Ltd. bought a new stake in Monsanto Company (NYSE:MON) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,673 shares of the basic materials company’s stock, valued at approximately $303,000.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Flossbach Von Storch AG boosted its position in shares of Monsanto by 33.9% in the first quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock valued at $462,920,000 after buying an additional 1,034,400 shares during the last quarter. Norges Bank bought a new position in Monsanto during the fourth quarter worth $406,735,000. UBS Asset Management Americas Inc. boosted its position in Monsanto by 55.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,181,090 shares of the basic materials company’s stock worth $246,899,000 after buying an additional 775,520 shares during the last quarter. Legal & General Group Plc boosted its position in Monsanto by 7.2% in the first quarter. Legal & General Group Plc now owns 2,124,147 shares of the basic materials company’s stock worth $240,459,000 after buying an additional 143,057 shares during the last quarter. Finally, Swiss National Bank boosted its position in Monsanto by 25.6% in the first quarter. Swiss National Bank now owns 1,676,066 shares of the basic materials company’s stock worth $189,731,000 after buying an additional 341,400 shares during the last quarter. 75.31% of the stock is currently owned by institutional investors and hedge funds.
Shares of Monsanto Company (MON) traded down 0.16% during trading on Tuesday, reaching $117.26. The company’s stock had a trading volume of 1,147,450 shares. The company has a 50 day moving average price of $117.53 and a 200 day moving average price of $114.77. The firm has a market capitalization of $51.52 billion, a P/E ratio of 25.33 and a beta of 1.07. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.19. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The business had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. During the same quarter last year, the business earned $2.17 earnings per share. The business’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, equities research analysts expect that Monsanto Company will post $4.89 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, July 7th were given a $0.54 dividend. The ex-dividend date of this dividend was Wednesday, July 5th. This represents a $2.16 annualized dividend and a yield of 1.84%. Monsanto’s dividend payout ratio (DPR) is 46.75%.
TRADEMARK VIOLATION NOTICE: This story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/08/08/rgt-capital-management-ltd-takes-position-in-monsanto-company-mon-updated-updated-updated.html.
Several analysts recently issued reports on the company. UBS AG downgraded Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. BidaskClub downgraded Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a research note on Wednesday, June 21st. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective on the stock in a research note on Tuesday, June 27th. Finally, Susquehanna Bancshares Inc reissued a “neutral” rating and set a $128.00 target price (up previously from $125.00) on shares of Monsanto in a research report on Tuesday, June 27th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $123.15.
In related news, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Janet M. Holloway sold 3,337 shares of Monsanto stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $118.00, for a total transaction of $393,766.00. Following the sale, the senior vice president now directly owns 44,405 shares of the company’s stock, valued at approximately $5,239,790. The disclosure for this sale can be found here. In the last 90 days, insiders sold 74,470 shares of company stock worth $8,791,281. 0.79% of the stock is currently owned by company insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.